The first patient in a multicenter, prospective study of Medtronic's Evolve workflow, which is designed for use in balancing low- and high-dose therapy settings and leveraged by the company's spinal cord stimulation systems, was enrolled at the Center for Interventional Pain and Spine in Delaware. The study, which will include up to 175 patients and up to 25 US sites, aims to evaluate chronic intractable pain patients undergoing spinal cord simulation with the use of the workflow and how their quality of life is affected by their access to high- and low-dose therapy through the procedure.
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.